Genetic variants at the carboxy terminal of the CaSR were studied and three single nucleotide polymorphisms at rs1042636, rs1801725 and rs1801726 were observed and this tri-locus haplotype could be considered as an outcome predictor in neuroblastoma patients. The gene discussed is CASR; the disease is neuroblastoma.